Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
The global production of scopolamine about 2450 Kg in 2015, the production region is mainly concentrated in Australia witch product 43.63% of global scopolamine. The top three companies are Alkaloids of Australia, Centroflora-cms and Fine Chemicals Corporation, they occupies about 62.37% market shares.
Although the production region is very concentration, the consumption region is very dispersion, in 2015, the largest consumption North America is about 30.68%, the Europe consumes about 26.65% market share, China occupies about 9.88% market share, Japan occupies about 10.78% market share.
The report offers detailed coverage of Scopolamine industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Scopolamine by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Scopolamine market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Scopolamine market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Alkaloids of Australia
Centroflora-cms
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin
At the same time, we classify Scopolamine according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Scopolamine Butylbromide
Scopolamine Hydrobromide
Scopolamine Base
Market by Application
Oral
Injection
Patches
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Scopolamine market for the forecast period 2021 - 2025?
• What are the driving forces in the Scopolamine market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Scopolamine industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?